Soluble NKG2D ligand (NKG2DL (when referring to the class collectively); no single canonical abbreviation for all soluble forms)

Soluble NKG2D ligands are shed or secreted forms of proteins that normally act as cell surface stress signals, recognized by the activating receptor NKG2D on natural killer (NK) cells and some T cells[2][3]. Canonical membrane-bound NKG2D ligands include MICA, MICB, and several UL16-binding proteins (ULBPs). These ligands can be shed through proteolytic cleavage (often by metalloproteases) or released in exosomes under conditions of cellular stress, transformation, or infection[2]. Soluble NKG2D ligands are found at elevated levels in the plasma of patients with various cancers and infectious diseases, where their presence can downregulate NKG2D expression on immune effector cells, impairing antitumor and antiviral immune responses and promoting immune evasion by tumors or infected cells. Measuring their levels is therefore clinically relevant as a marker of disease progression, prognosis, and therapy response. Because they modulate both immune surveillance and immune evasion, soluble NKG2D ligands are considered both disease biomarkers and therapeutic targets[2][3].

Other names

Soluble NKG2D ligandSoluble MICASoluble MICBSoluble ULBPSoluble NKG2D ligand familyShed NKG2D ligand

Antagonists or neutralizing antibodies bind to soluble NKG2D ligands, aiming to restore NKG2D receptor function on immune cells[3]. Inhibitors of protease-mediated shedding prevent the release of soluble ligands, preserving cell surface ligand and promoting immune targeting of diseased cells[3].